Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Overcoming double standard policies towards expansion of opioid substitution treatment (OST) in Ukraine
Presentation from Oleksandr Lebega from International HIV/AIDS Alliance in Ukraine at the AIDS 2012 conference.
Presentation from Oleksandr Lebega from International HIV/AIDS Alliance in Ukraine at the AIDS 2012 conference.
Evidence-based drug policy in four African countries: barriers and opportunities
Webcast of Joanne Csete's from the Global Drug Policy Program presentation at the AIDS 2012 conference.
Webcast of Joanne Csete's from the Global Drug Policy Program presentation at the AIDS 2012 conference.
HIV, Drug-Use and Risks in Different Contexts
Webcasts from the "HIV, Drug-Use and Risks in Different Contexts" oral abstracts session at the AIDS 2012 conference.
Webcasts from the "HIV, Drug-Use and Risks in Different Contexts" oral abstracts session at the AIDS 2012 conference.
Harm Reduction: Availability, Coverage, Expansion and Efficacy
Webcasts from the "Harm Reduction: Availability, Coverage, Expansion and Efficacy" oral abstracts sessions at the AIDS conference.
Webcasts from the "Harm Reduction: Availability, Coverage, Expansion and Efficacy" oral abstracts sessions at the AIDS conference.
DRUG USE AMONG MEN WHO HAVE SEX WITH MEN - Implications for harm reduction
"The chapter begins with an overview of the range of drugs taken by MSM, followed by a description of prevalence across the world (where such data exist) and a discussion of data quality. It then assesses the reasons for drug use by MSM and the harms that may be associated with such use. The final section highlights interventions to help reduce the harms associated with drug use among MSM."
"The chapter begins with an overview of the range of drugs taken by MSM, followed by a description of prevalence across the world (where such data exist) and a discussion of data quality. It then assesses the reasons for drug use by MSM and the harms that may be associated with such use. The final section highlights interventions to help reduce the harms associated with drug use among MSM."
AIDS 2012 - Harm Reduction Roadmap
This document is the Harm Reduction Roadmap for the AIDS 2012 conference in Washington DC 22 - 27 July 2012.
This document is the Harm Reduction Roadmap for the AIDS 2012 conference in Washington DC 22 - 27 July 2012.
A Balancing Act: Policymaking on Illicit Drugs in the Czech Republic
This is the third study on good practices in national drug policy from Global Drug Policy Program. The document highlights how the Czech Republic has kept low-threshold health services high on the drug policy agenda, engaged with civil society, invested seriously in research on the impact of drug policy, and managed the shifting political winds of public attitudes toward drugs.
This is the third study on good practices in national drug policy from Global Drug Policy Program. The document highlights how the Czech Republic has kept low-threshold health services high on the drug policy agenda, engaged with civil society, invested seriously in research on the impact of drug policy, and managed the shifting political winds of public attitudes toward drugs.
The Global State of Harm Reduction 2012; Towards an Intergrated Response report
This report highlights the major developments in harm reduction policy adoption and programme implementation that have occurred since 2010, enabling some assessment of global progress. It also explores several key issues for developing an integrated harm reduction response, such as building effective harm reduction services for women who inject drugs, access to harm reduction services by young people, drug use among men who have sex with men, global progress toward drug decriminalisation and sustainability of services in challenging environments.
This report highlights the major developments in harm reduction policy adoption and programme implementation that have occurred since 2010, enabling some assessment of global progress. It also explores several key issues for developing an integrated harm reduction response, such as building effective harm reduction services for women who inject drugs, access to harm reduction services by young people, drug use among men who have sex with men, global progress toward drug decriminalisation and sustainability of services in challenging environments.
Home Affairs Committee: Drugs
Danny Kushlink, Transform Drug Policy Foundation, Niamh Eastwood, Release, Tom Lloyd, former Chief Constable of Cambridgeshire Trevor Pearce, Director General, Serious and Organised Crime Agency give evidence to the Home Affairs Committee in relation to the inquiry into drugs.
Danny Kushlink, Transform Drug Policy Foundation, Niamh Eastwood, Release, Tom Lloyd, former Chief Constable of Cambridgeshire Trevor Pearce, Director General, Serious and Organised Crime Agency give evidence to the Home Affairs Committee in relation to the inquiry into drugs.
Drugs Meter
Check out the new Drugs Meter, a new tool which allows people to get non-judgmental feedback on their drug use, including alcohol.
Check out the new Drugs Meter, a new tool which allows people to get non-judgmental feedback on their drug use, including alcohol.
